NAC1, A POZ/BTB protein interacts with Parkin and may contribute to Parkinson's disease

Neuroscience

Volumn 257, Issue , 2014, Pages 86-95

  Korutla, L ^a   Furlong, H A ^a   Mackler, S A ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Aggregates; Co immunoprecipitation; Co localization; Degradation; Down regulation; Proteasome

Indexed keywords

BRAIN PROTEIN; GLUTATHIONE TRANSFERASE; NUCLEUS ACCUMBENS 1 PROTEIN; PARKIN; PROTEASOME; RNA; UBIQUITIN; UNCLASSIFIED DRUG;

ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOPLASM; DOPAMINERGIC NERVE CELL; DOWN REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MESENCEPHALON; MUTATION; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION;

3-[4,5-DIMETHYLTHIAZOL-2-YL]-2,5 DIPHENYL TETRAZOLIUM BROMIDE; 4′,6-DIAMIDINO-2-PHENYLINDOLE; AGGREGATES; CO-IMMUNOPRECIPITATION; CO-LOCALIZATION; DAPI; DEGRADATION; DOWN-REGULATION; GAPDH; GLUTATHIONE S-TRANSFERASE; GLYCERALDEHYDE 3-PHOSPHATE DEHYDROGENASE; GST; MTT; NAC; NUCLEUS ACCUMBENS; PARKINSON'S DISEASE; PBS; PCR; PD; PHOSPHATE-BUFFERED SALINE; POLYMERASE CHAIN REACTION; PROTEASOME; SDS-PAGE; SODIUM DODECYL SULFATE-POLYACRYLAMIDE GEL ELECTROPHORESIS; UBIQUITIN-PROTEASOME SYSTEM; UPS;

AGED, 80 AND OVER; ANIMALS; BRAIN; CELL LINE, TRANSFORMED; CENTRAL NERVOUS SYSTEM; CYSTEINE PROTEINASE INHIBITORS; CYTOPLASM; DOWN-REGULATION; GLUTATHIONE TRANSFERASE; HUMANS; IMMUNOPRECIPITATION; LEUPEPTINS; MALE; MICE; NERVE TISSUE PROTEINS; NEURONS; PARKINSON DISEASE; PROTEASOME ENDOPEPTIDASE COMPLEX; REPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES;

EID: 84889589633     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2013.11.001     Document Type: Article

References (25)

1. Bertoli-Avella A.M., Giroud-Benitez J.L., Bonifati V., Alvarez-Gonzalez E., Heredero-Baute L., van Duijn C.M., Heutink P. Suggestive linkage to chromosome 19 in a large Cuban family with late-onset Parkinson's disease. Mov Disord 2003, 18:1240-1249.
2. Cha X.Y., Pierce R.C., Kalivas P.W., Mackler S.A. NAC-1, a rat brain mRNA, is increased in the nucleus accumbens three weeks after chronic cocaine self-administration. J Neurosci 1997, 17:6864-6871.
3. Chung K.K., Dawson V.L., Dawson T.M. The role of the ubiquitin-proteasomal pathway in Parkinson's disease and other neurodegenerative disorders. Trends Neurosci 2001, 24:S7-S14.
4. Corti O., Hampe C., Koutnikova H., Darios F., Jacquier S., Prigent A., Robinson J.C., Pradier L., Ruberg M., Mirande M., Hirsch E., Rooney T., Fournier A., Brice A. The p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration. Hum Mol Genet 2003, 12:1427-1437.
5. Crawford G.D., Le W.D., Smith R.G., Xie W.J., Stefani E., Appel S.H. A novel N18TG2×mesencephalon cell hybrid expresses properties that suggest a dopaminergic cell line of substantia nigra origin. J Neurosci 1992, 12:3392-3398.
6. Dawson T.M. New animal models for Parkinson's disease. Cell 2000, 101:115-118.
7. Galvin J.E., Lee V.M., Schmidt M.L., Tu P.H., Iwatsubo T., Trojanowski J.Q. Pathobiology of the Lewy body. Adv Neurol 1999, 80:313-324.
8. Imai Y., Soda M., Murakami T., Shoji M., Abe K., Takahashi R. A product of the human gene adjacent to parkin is a component of Lewy bodies and suppresses Pael receptor-induced cell death. J Biol Chem 2003, 278:51901-51910.
9. Kitada T., Asakawa S., Hattori N., Matsumine H., Yamamura Y., Minoshima S., Yokochi M., Mizuno Y., Shimizu N. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998, 392:605-608.
10. Korutla L., Wang P.J., Lewis D.M., Neustadter J.H., Stromberg M.F., Mackler S.A. Differences in expression, actions and cocaine regulation of two isoforms for the brain transcriptional regulator NAC1. Neuroscience 2002, 110:421-429.
11. Lang A.E., Lozano A.M. Parkinson's disease. First of two parts. N Engl J Med 1998, 339:1044-1053.
12. Lang A.E., Lozano A.M. Parkinson's disease. Second of two parts. N Engl J Med 1998, 339:1130-1143.
13. -DDCt method. Methods 2001, 25(4):402-408.
14. Lucking C.B., Durr A., Bonifati V., Vaughan J., De Michele G., Gasser T., Harhangi B.S., Meco G., Denefle P., Wood N.W., Agid Y., Brice A. Association between early-onset Parkinson's disease and mutations in the Parkin gene. New Engl J Med 2000, 342:1560-1567.
15. Mackler S.A., Korutla L., Cha X.Y., Koebbe M.J., Fournier K.M., Bowers M.S., Kalivas P.W. NAC-1 is a brain POZ/BTB protein that can prevent cocaine-induced sensitization in the rat. J Neurosci 2000, 20:6210-6217.
16. Matilla A., Gorbea C., Einum D.D., Townsend J., Michalik A., Van Broeckhoven C., Jensen C.C., Murphy K.J., Ptacek L.J., Fu Y.H. Association of ataxin-7 with the proteasome subunit S4 of the 19S regulatory complex. Hum Mol Genet 2001, 10:2821-2831.
17. McNaught K.S., Olanow C.W. Proteolytic stress: a unifying concept for the etiopathogenesis of Parkinson's disease. Ann Neurol 2003, 53(Suppl. 3):S73-S84. (discussion S84-76).
18. Olanow C.W., Tatton W.G. Etiology and pathogenesis of Parkinson's disease. Annu Rev Neurosci 1999, 22(1).
19. Shen H., Korutla L., Champtiaux N., Toda S., LaLumiere R., Vallone J., Klugmann M., Blendy J.A., Mackler S.A., Kalivas P.W. NAC1 regulates the recruitment of the proteasome complex into dendritic spines. J Neurosci 2007, 27:8903-8913.
20. Shih Ie.M., Nakayama K., Wu G., Nakayama N., Zhang J., Wang T.L. Amplification of the ch19p13.2 NACC1 locus in ovarian high-grade serous carcinoma. Mod Pathol 2011, 24:638-645.
21. Shimura H., Hattori N., Kubo S., Mizuno Y., Asakawa S., Minoshima S., Shimizu N., Iwai K., Chiba T., Tanaka K., Suzuki T. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat Genet 2000, 25:302-305.
22. Sieuwerts A.M., Klijn J.G., Peters H.A., Foekens J.A. The MTT tetrazolium salt assay scrutinized: how to use this assay reliably to measure metabolic activity of cell cultures in vitro for the assessment of growth characteristics, IC50-values and cell survival. European Journal of Clinical Chemistry and Clinical Biochemistry 1995, 33:813-823.
23. Snyder H., Mensah K., Theisler C., Lee J., Matouschek A., Wolozin B. Aggregated and monomeric alpha-synuclein bind to the S6' proteasomal protein and inhibit proteasomal function. J Biol Chem 2003, 278:11753-11759.
24. Vila M., Przedborski S. Genetic clues to the pathogenesis of Parkinson's disease. Nat Med 2004, 10(Suppl.):S58-S62.
25. Yang H., Zhou H.-Y., Li B., Niu G.-Z., Chen S.-D. Downregulation of Parkin damages antioxidant defenses and enhances proteasome inhibition-induced toxicity in PC12 cells. J Neuroimmune Pharmacol 2007, 2:276-283.